NanoCrySP Nanocrystals
USP: The technology is readily industrially scaleable, produces solid powder of NCSD which requires minimal downstream processing to covert it to final dosage form. In contrst to exixting top down based milling techniques and bottom up methods of nanocrystal generation, NaoCrySP offers minimal drug degradation and impurities during the process. Technology also opens up newer delivery routes for nanocrystals like in pulmonary and topical routes
- Innovator's Name
- Product/Technology Description
WINDLAS BIOTECH LIMITED
Windlas Biotech Pvt. Ltd. is WHO-GMP certified Company committed to take an innovative, responsible and sustainable approach towards meeting the healthcare challenges of mankind. Our Companys Strength lies in the Manufacture of Products in dosage form of Tablets, capsule, liquid orals and small volume of sachets. We have a separate Marketing Team dedicated to Market our own Brand Products. We have well equipped laboratory and pilot plant with state-of-art equipment. Our highly qualified staff ensure quality minded production.
- Product Name: NanoCrySP Nanocrystals
- Product Title: Celecoxib and Curcumin Nanocyrstalline Solid Dispersion NCSD based tablets
- Description: NanoCrySP is a bottom-up platform spray drying based tecchnology for generation of nanocrystals in presence of small molecule excipient like mannitol. The excipient play three roles in generation and stabilization of nanocrystals- i heterogenous nucleation ii Plasticization iii Physical barrier to crystal growth. The nanocrystals of size 1000 nm are obtained embedded in the matrix of excipient 5-20 micron . The nanocrystals would enhance solubility, dissolution rate, decrease the onset of action manifested as left shift in Tmax , reduction in food effect and intersubject variability
- Unique Selling Point: The technology is readily industrially scaleable, produces solid powder of NCSD which requires minimal downstream processing to covert it to final dosage form. In contrst to exixting top down based milling techniques and bottom up methods of nanocrystal generation, NaoCrySP offers minimal drug degradation and impurities during the process. Technology also opens up newer delivery routes for nanocrystals like in pulmonary and topical routes
